Charles S. Lieber
Section of Liver Disease and Nutrition
James J. Peters VA Medical Center
130 West Kingsbridge Road (151-2)
Bronx
USA
Name/email consistency: high
- Alcohol alters hepatic FoxO1, p53, and mitochondrial SIRT5 deacetylation function. Lieber, C.S., Leo, M.A., Wang, X., Decarli, L.M. Biochem. Biophys. Res. Commun. (2008)
- Beneficial effects versus toxicity of medium-chain triacylglycerols in rats with NASH. Lieber, C.S., DeCarli, L.M., Leo, M.A., Mak, K.M., Ponomarenko, A., Ren, C., Wang, X. J. Hepatol. (2008)
- Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Lieber, C.S., Weiss, D.G., Paronetto, F. Alcohol. Clin. Exp. Res. (2008)
- Effect of chronic alcohol consumption on Hepatic SIRT1 and PGC-1alpha in rats. Lieber, C.S., Leo, M.A., Wang, X., Decarli, L.M. Biochem. Biophys. Res. Commun. (2008)
- Role of medium-chain triglycerides in the alcohol-mediated cytochrome P450 2E1 induction of mitochondria. Lieber, C.S., Cao, Q., DeCarli, L.M., Leo, M.A., Mak, K.M., Ponomarenko, A., Ren, C., Wang, X. Alcohol. Clin. Exp. Res. (2007)
- Metabolism of alcohol. Lieber, C.S. Clin. Liver. Dis (2005)
- New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments. Lieber, C.S. Curr. Gastroenterol. Rep (2004)
- The unexpected outcomes of medical research: serendipity and the microsomal ethanol oxidizing system. Lieber, C.S. J. Hepatol. (2004)
- Model of nonalcoholic steatohepatitis. Lieber, C.S., Leo, M.A., Mak, K.M., Xu, Y., Cao, Q., Ren, C., Ponomarenko, A., DeCarli, L.M. Am. J. Clin. Nutr. (2004)
- Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Lieber, C.S. Alcohol (2004)
- Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. Lieber, C.S., Leo, M.A., Cao, Q., Ren, C., DeCarli, L.M. J. Clin. Gastroenterol. (2003)
- I. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease: effects on drinking behavior by nurse/physician teams. Lieber, C.S., Weiss, D.G., Groszmann, R., Paronetto, F., Schenker, S. Alcohol. Clin. Exp. Res. (2003)
- II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Lieber, C.S., Weiss, D.G., Groszmann, R., Paronetto, F., Schenker, S. Alcohol. Clin. Exp. Res. (2003)
- S-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings. Lieber, C.S. Alcohol (2002)
- S-Adenosylmethionine: molecular, biological, and clinical aspects--an introduction. Lieber, C.S., Packer, L. Am. J. Clin. Nutr. (2002)
- S-adenosyl-L-methionine: its role in the treatment of liver disorders. Lieber, C.S. Am. J. Clin. Nutr. (2002)
- Liver diseases by alcohol and hepatitis C: early detection and new insights in pathogenesis lead to improved treatment. Lieber, C.S. Am. J. Addict (2001)
- Alcoholic liver injury: pathogenesis and therapy in 2001. Lieber, C.S. Pathol. Biol. (2001)
- Alcoholic liver disease: new insights in pathogenesis lead to new treatments. Lieber, C.S. J. Hepatol. (2000)
- Ethnic and gender differences in ethanol metabolism. Lieber, C.S. Alcohol. Clin. Exp. Res. (2000)
- ALCOHOL: its metabolism and interaction with nutrients. Lieber, C.S. Annu. Rev. Nutr. (2000)
- The Research Society on Alcoholism (RSA): 1976-2000. Lieber, C.S. Alcohol. Clin. Exp. Res. (2000)
- Prevention and treatment of liver fibrosis based on pathogenesis. Lieber, C.S. Alcohol. Clin. Exp. Res. (1999)
- Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)--a review. Lieber, C.S. Alcohol. Clin. Exp. Res. (1999)
- Carbohydrate deficient transferrin in alcoholic liver disease: mechanisms and clinical implications. Lieber, C.S. Alcohol (1999)